Marzena Rams‐Baron

Design, Synthesis and In Vitro Activity of Anticancer Styrylquinolines. The p53 Independent Mechanism of Action

Anna Mrozek‐Wilczkiewicz, Ewelina Spaczyńska, Katarzyna Malarz et al. · PLoS ONE · 2015 · 54 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +19

Molecular Dynamics, Recrystallization Behavior, and Water Solubility of the Amorphous Anticancer Agent Bicalutamide and Its Polyvinylpyrrolidone Mixtures

Justyna Szczurek, Marzena Rams‐Baron, Justyna Knapik-Kowalczuk et al. · Molecular Pharmaceutics · 2017 · 50 citations · Full text

Engineering, Amorphous Bicalutamide, Chemistry +19

Co-Stabilization of Amorphous Pharmaceuticals—The Case of Nifedipine and Nimodipine

Justyna Knapik-Kowalczuk, Wenkang Tu, Krzysztof Chmiel et al. · Molecular Pharmaceutics · 2018 · 44 citations

Pharmaceutical Science, Engineering, Pharmacotherapy +20

Toward a Better Understanding of the Physical Stability of Amorphous Anti-Inflammatory Agents: The Roles of Molecular Mobility and Molecular Interaction Patterns

Marzena Rams‐Baron, Ż. Wojnarowska, K. Grzybowska et al. · Molecular Pharmaceutics · 2015 · 39 citations

Crystallization Tendencies, Engineering, Molecular Interaction Patterns +18

Atorvastatin as a Promising Crystallization Inhibitor of Amorphous Probucol: Dielectric Studies at Ambient and Elevated Pressure

Justyna Knapik-Kowalczuk, Ż. Wojnarowska, Marzena Rams‐Baron et al. · Molecular Pharmaceutics · 2017 · 36 citations

Engineering, Promising Crystallization Inhibitor, Liquid Crystalline Elastomer +16